Notícias · Recifes

Three-in-one vaccine shows promise against 'tripledemic'

Flu season is no longer just flu season. Since 2022, the health care community has faced what's known as a "tripledemic" of seasonal influenza, COVID-19 and respiratory syncytial virus (RSV). That may mean the flu shot needs to become more than a flu shot.

Admin Recifes 15/07/2026 8

Photoswitch drug shows early signs of restoring light sensitivity in severely damaged reti

Adelaide University researchers have carried out the first in-human trial of a new type of treatment for a leading cause of blindness in working age adults, with promising results.

Admin Recifes 15/07/2026 9

Experimental vaccine for 'neglected disease' carried by hundreds of millions of people sho

For a vaccine to be effective, it must do two things. First, it must trigger an immune response. Second, the vaccine must train the body to remember the response so it can fight that same disease in the future. Now, new research shows that the only vaccine being tested to prevent

Admin Recifes 15/07/2026 8

Billions of doses later: Global review confirms mRNA vaccines are safe, effective and full

A sweeping global review led by researchers at the University of British Columbia has found that mRNA vaccines—now administered billions of times worldwide—are safe and highly effective at preventing infectious diseases like COVID-19, and have potential applications for a range o

Admin Recifes 15/07/2026 10

Study shows promise of non-surgical treatment for slipped disks

When the soft, cushion-like disks in the spine become injured or start to bulge, the effects can be debilitating. O recorte ajuda a contextualizar a pauta dentro de Fitness.

Admin Recifes 15/07/2026 9

The hidden risks of gray‑market peptides: Why women face greater danger

A wave of unregulated peptides is sweeping the wellness world, sold online with bold promises about muscle gain, anti-aging and fat loss. But concern is growing about side effects, and almost nobody is asking whether these substances affect men and women in the same way. The evid

Admin Recifes 15/07/2026 7

Investigators report promising results from Phase II trial of targeted therapy for rare bi

Results of the ongoing eNRGy trial, a single-arm, multicenter, global Phase II clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable side effects and clinically meaningful efficacy—including a near doubling of p

Admin Recifes 15/07/2026 7

Five hidden pitfalls of fitness tracking

Many people in the U.K. now use apps, smartwatches or wearable devices to track their physical activity. Fitness trackers promise to help users become fitter, happier and healthier versions of themselves. For many people, they can be useful: a nudge to move more, a way to notice

Admin Recifes 15/07/2026 9

Novel biomarker research offers new hope in the fight against colorectal cancer

Emerging discoveries in liquid biomarker research promise to transform the early detection, diagnosis and treatment monitoring of colorectal cancer (CRC), according to a new study, offering less invasive alternatives to traditional methods that often require surgical intervention

Admin Recifes 15/07/2026 9

Paying stores to curb tobacco, alcohol and lottery ads shows early promise

An initiative focused on partnering with retailers to decrease the influence of tobacco, alcohol and lottery marketing is showing promise and could present a more effective way to protect public health throughout the country, according to researchers at The Ohio State University.

Admin Recifes 15/07/2026 7

Researchers develop potential nonhormonal therapy to repair vaginal tissue damaged by meno

Researchers at the University of Colorado Anschutz have developed a promising nonhormonal therapy for women experiencing Genitourinary Syndrome of Menopause (GSM). GSM is a common chronic condition caused by declining estrogen levels that affects the vulva, vagina and urinary tra

Admin Recifes 15/07/2026 7

Promising medication combination to treat an 'undruggable' type of lung cancer

Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for thousands of patients with lung cancer driven by a rare type of KRAS mutation, offering hope for patients worldwide with this difficult-to-treat subtype of

Admin Recifes 15/07/2026 7

Acompanhe as Notícias da Recifes